BioInvent and Transgene Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA(R) – Stocks News Feed
LUND, SWEDEN / ACCESSWIRE / June 28, 2022 / BioInvent International (STO:BINV) Lund, Sweden – June 28, 2022 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused…